retatrutide weight loss trial data VisualAbstract: reduces body by 17.5% in patients with obesity retatrutide weight loss phase 2

EMA Statement on Ongoing Review of GLP-1 Receptor Agonists (EMA, 2023)

1 Under hyperglycaemic conditions, GLP-1 inhibits glucagon secretion, stimulates insulin release, and increases glucose uptake in muscle and liver cells to lower blood glucose levels

Cognition Its uncertain how L-carnitine affects cognition since clinical trials are limited

Currently, radiation treatments encompass various methods, including external radiotherapy, internal radiotherapy, nuclide internal radiation therapy, and heavy ion radiotherapy

27,28 Table 1 details additional studies that show a higher prevalence of caries in those with ASD